IV PERSANTINE Reviews (DIPYRIDAMOLE)

Average Rating: 1.0 (2 Ratings)

Filter Results

Compare IV PERSANTINE with similar:
 CORONARY VASODILATORS CORONARY VASODILATORS

 Type: Rx Drug

  

IV PERSANTINE  (DIPYRIDAMOLE):  This medication is used in combination with "blood thinners" such as warfarin to keep clots from forming after heart valve replacements. Clots are a serious complication that can cause strokes, heart attacks, or blocked blood vessels in the lungs (pulmonary embolisms). Dipyridamole is an antiplatelet drug. It helps to keep blood flowing by stopping platelets from clumping together and by keeping heart blood vessels open.   FDA Approval Date: 1990-12-13 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR IV PERSANTINECOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 1  Could not do the treadmill test Tightness in chest, very hard to breath, flushed, sever headache Would never allow this to be administered again. Worst feeling ever in my life. F 65 1 days
10/7/2006
Email
 1  For Sestamibi exercise Stress Test Severe Headache. It felt like my head was going to burst with the pressure. Tightness and major pressure in my neck and jaw. Feelings of agitation ++. These symptoms lasted up to 20 minutes It was a very unpleasant experience and I would not have this medication again F 58 1 days
1/12/2005
  

IV PERSANTINE  (DIPYRIDAMOLE):  This medication is used in combination with "blood thinners" such as warfarin to keep clots from forming after heart valve replacements. Clots are a serious complication that can cause strokes, heart attacks, or blocked blood vessels in the lungs (pulmonary embolisms). Dipyridamole is an antiplatelet drug. It helps to keep blood flowing by stopping platelets from clumping together and by keeping heart blood vessels open.   FDA Approval Date: 1990-12-13 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP